GSK's vaccine operating profit, margin dive on Novartis fold-in

[anonymous]

[Send moncef off to do this, send moncef off to do that! Let moncef take care of some Mickey Mouse nightclub somewhere! Send moncef to pick somebody up at the airport! I'm your older brother, Mike, and I was stepped over!
Sir andie: That's the way PV wanted it.
Moncef: It ain't the way I wanted it! I can handle things! I'm smart! Not like everybody says! Like, dumb. I'm smart, and I want respect!
Sir andwew: [unmoved] Is there anything you can tell me about this vaccine?

 

[anonymous]

his Vile Stupidity has been the downfall of the pipeline!

 

[anonymous]

The pipeline is trounced in sedition and fully recovered from 1989 torment. None of the riches of Belfast nor Antwerp can subdue the anxiety of tablets or capsules ! Down with the competitors of Kleenex and Charmin ; we are the winners.

 

[anonymous]

Net-Net he didn't spend a penny on NVD. The deal was that Novartis overpaid ~ $1.5B for Oncology then, in return, GSK paid $1.5B for NVD vaccines. That is how badly Novartis wanted to get rid of NVD. As long as GSK cuts costs at former NVD before it losing money on it, it a wash. The folks inherited from there are toast.

Gsk will lose money on the vaccines deal....it was a dumb and dumber three deal...It will never be able to make the supply chain efficient an most importantly it doesn't have the right managers

 

[anonymous]

Yep. Another Big Pharma looked closely at NVS vaccines and walked away very quickly. Apparently Moncef is again responsible for sloppy decisions, just like the colossal $720 million he is responsible for wasting on Sirtris. His brilliant strategy of trusting external scientists more than internal ones.